News Briefs

✦ Novo Nordisk Inc. on Jan 2 launched three new strategies to make insulin more affordable for patients. The My$99Insulin Program allows eligible patients — with or without insurance — to get up to three vials or two packs of any combination of Novo Nordisk insulin products for $99 by enrolling on NovoCare.com and downloading an online card that can be redeemed at a pharmacy. In addition, authorized generic versions of NovoLog and NovoLog Mix will now be stocked at the wholesaler level, and patients can order them at the pharmacy and pick them up in one to three business days. Finally, Novo Nordisk said that in order to prevent insulin rationing, in some cases it will provide a free, one-time, immediate supply of up to three vials or two packs of pens of Novo Nordisk insulin for individuals with a prescription. Read more at https://prn.to/2QSw0GW.

✦ A machine learning system can do a better job of preventing medication errors than clinical decision support (CDS) tools such as alerts and reminders, according to a new study. The study, published in the January edition of The Joint Commission Journal on Quality and Patient Safety, analyzed outpatient data from Brigham and Women’s Hospital and Massachusetts General Hospital in Boston to determine whether a machine learning system generated clinically valid alerts, then compared the alerts to those generated by an existing CDS system. It found that 68.2% of the alerts produced by the machine learning system would not have been generated by the existing CDS system, 92% of a random sample of the chart-reviewed alerts were accurate, and 80% were clinically valid. The study also estimated that the machine learning system could have saved more than $60 per drug alert by potentially preventing adverse events in an outpatient setting, and $1.3 million when extrapolating the findings to the full patient population. Visit https://bit.ly/2ZXqlU0.

0

0

0 Comments

0

0

• Radar on Drug Benefits